Christina S. Meade

Christina S. Meade

Associate Professor in Psychiatry and Behavioral Sciences

External Address: 
905 W. Main Street, Suite 24-E, Durham, NC 27701
Internal Office Address: 
905 W. Main Street, Box 102848, Durham, NC 27710
Phone: 
919.613.6549

Overview

Dr. Meade’s domestic research program focuses on predictors of HIV risk behavior in adults with substance use and psychiatric disorders, and the relationship between neuropsychiatric conditions and continued risk behavior in HIV-positive adults. She is particularly interested in how drug addiction and HIV infection impact executive functions, such as decision making, that lead individuals to engage in risky behaviors. Many of her current projects incorporate MRI to isolate the effects of addiction and HIV on both brain function and structure. Dr. Meade is also interested in the development of evidence-based treatments to improve cognitive functioning and reduce risk behaviors among drug users.

Given that most people infected or affected by HIV/AIDS live in Sub-Saharan Africa, Dr. Meade’s international research program is based in South Africa. The Western Cape has experienced a dramatic increase in methamphetamine use since the early 2000s, and there is concern that it may further fuel the HIV epidemic in this country. Current projects focus on characterizing drug addiction and HIV risk behaviors in this understudied group, both in in community and treatment settings, and ultimately increasing uptake of HIV services to improve health outcomes and reduce the continued spread of HIV.

Education & Training

  • Ph.D., Yale University 2006

Selected Grants

NeuroAIDS research with disadvantaged drug users awarded by National Institutes of Health (Principal Investigator). 2014 to 2017

A Compute Cluster for Brain Imaging and Analysis awarded by National Institutes of Health (Minor User). 2016 to 2017

Effects of Cocaine and HIV Decision Making Involving Potential Loss awarded by National Institutes of Health (Principal Investigator). 2013 to 2016

Neural Substrates Associated with Executive Functioning in Marijuana and HIV awarded by National Institutes of Health (Principal Investigator). 2014 to 2016

Neurocognitive Impact of Marijuana Use in Patients with HIV/AIDS awarded by National Institutes of Health (Principal Investigator). 2013 to 2015

Neurobehavioral and fMRI Research in HIV Infection and Cocaine Dependence awarded by National Institutes of Health (Principal Investigator). 2010 to 2015

HIV risk behaviors among methamphetamine users in Cape Town, South Africa awarded by National Institutes of Health (Principal Investigator). 2012 to 2015

CFAR Minority Supplement:Mentor Meade awarded by National Institutes of Health (Mentor). 2010 to 2015

Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments awarded by National Institutes of Health (Co Investigator). 2012 to 2014

Brief Care-based HIV Prevention for Newly Diagnosed Men awarded by National Institutes of Health (Co Investigator). 2009 to 2012

Pages

Tamargo, Javier A., et al. “Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort.J Psychoactive Drugs, vol. 53, no. 3, July 2021, pp. 215–23. Pubmed, doi:10.1080/02791072.2020.1850946. Full Text

Hall, Shana A., et al. “Hypoactivation in the precuneus and posterior cingulate cortex during ambiguous decision making in individuals with HIV.J Neurovirol, vol. 27, no. 3, June 2021, pp. 463–75. Pubmed, doi:10.1007/s13365-021-00981-1. Full Text

Towe, Sheri L., et al. “Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.Aids Behav, vol. 25, no. 5, May 2021, pp. 1480–89. Pubmed, doi:10.1007/s10461-020-02987-y. Full Text

Towe, Sheri L., et al. “Web-Based Cognitive Training to Improve Working Memory in Persons with Co-Occurring HIV Infection and Cocaine Use Disorder: Outcomes from a Randomized Controlled Trial.Aids Behav, vol. 25, no. 5, May 2021, pp. 1542–51. Pubmed, doi:10.1007/s10461-020-02993-0. Full Text

Tamargo, Javier A., et al. “Food Insecurity and Cognitive Impairment in the Miami Adult Studies on HIV (MASH) Cohort.J Nutr, vol. 151, no. 4, Apr. 2021, pp. 979–86. Pubmed, doi:10.1093/jn/nxaa416. Full Text

Pacek, Lauren R., et al. “Experiences With Smoking Cessation Attempts and Prior Use of Cessation Aids in Smokers With HIV: Findings From a Focus Group Study Conducted in Durham, North Carolina.Aids Educ Prev, vol. 33, no. 2, Apr. 2021, pp. 158–68. Pubmed, doi:10.1521/aeap.2021.33.2.158. Full Text Open Access Copy

Pacek, Lauren R., et al. “Cigarette Smoking and Cessation-Related Interactions With Health Care Providers in the Context of Living With HIV: Focus Group Study Findings.J Assoc Nurses Aids Care, vol. 32, no. 2, Mar. 2021, pp. e14–19. Pubmed, doi:10.1097/JNC.0000000000000185. Full Text Open Access Copy

Xu, Yunan, et al. “Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data.J Neurovirol, vol. 27, no. 1, Feb. 2021, pp. 1–11. Pubmed, doi:10.1007/s13365-020-00930-4. Full Text

Hall, Shana A., et al. “Synergistic effects of HIV and marijuana use on functional brain network organization.Prog Neuropsychopharmacol Biol Psychiatry, vol. 104, Jan. 2021, p. 110040. Pubmed, doi:10.1016/j.pnpbp.2020.110040. Full Text

Causey, Shakiera T., et al. “Perceived Healthcare Access among Persons with and without HIV Who Use Illicit Stimulants: The Role of Cumulative Risk.Subst Use Misuse, vol. 56, no. 9, 2021, pp. 1387–96. Pubmed, doi:10.1080/10826084.2021.1928211. Full Text

Pages